share_log

雪榕生物(300511.SZ):拟以债转股方式对全资子公司增资

Snow Rong Biology (300511.SZ): plans to increase capital to wholly-owned subsidiaries by way of debt-to-equity swap

格隆滙 ·  Dec 10, 2021 05:20

Gelonghui (300511.SZ) announced that in order to optimize the capital structure of its wholly-owned subsidiaries Shandong Xuelong Biotechnology Co., Ltd. ("Shandong Xuerong") and Weining Xuerong Biotechnology Co., Ltd. ("Weining Xuerong"), enhance its financial strength and enhance its financing capacity. The board of directors of the company agreed to transfer the claims corresponding to 65 million yuan received from Shandong Xuerong and 100 million yuan due from Weining Xuerong as capital increase to it respectively. After the completion of this capital increase, Shandong Xuerong's registered capital will increase from the original 570 million yuan to 635 million yuan, Weining Xuerong's registered capital will increase from the original 80 million yuan to 180 million yuan, and the company's shareholding ratio will remain unchanged.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment